← Back to patent-cliff list
米索前列醇
Tier C — Watch / tradeMisoprostol
辉瑞
Originator
1984
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：PTGER2
Brand：Isprelor、Cytotec、Mysodelle、Misodel、Angusta、Misopess、Misotac、Vagiprost、GyMiso
Indications (approved)：终止妊娠、十二指肠溃疡、胃溃疡、胃癌、消化性溃疡
Regional status
US
批准上市
1988-12-27
EU
批准上市
1984-06-28
China
批准上市
1996-01-01
Japan
批准上市
1993-01-19
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Misoprostol?
Approved indications include: 终止妊娠, 十二指肠溃疡, 胃溃疡, 胃癌, 消化性溃疡.
When does the Misoprostol patent expire?
No public expiry year is available for Misoprostol yet; this page updates once verified.
How do I get a quote for Misoprostol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25